| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6166927 | Urology | 2014 | 7 Pages |
Abstract
These preclinical data provide a proof of mechanism for DA-8031 as a novel compound of targeting the SERT for the treatment of premature ejaculation, warranting further clinical trials. They also offer insight into the optimal drug dose needed to exert therapeutic effects while minimizing adverse effects in humans.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
![Proof of Mechanism Study of a Novel Serotonin Transporter Blocker, DA-8031, Using [11C]DASB Positron Emission Tomography and In Vivo Microdialysis](/preview/png/6166927.png "First Page Preview: Proof of Mechanism Study of a Novel Serotonin Transporter Blocker, DA-8031, Using [11C]DASB Positron Emission Tomography and In Vivo Microdialysis")
Authors
Hyun Soo Park, In Soon Jung, Nam Hee Lim, Ji Hyun Sung, Sukhyang Lee, Byung Seok Moon, Byung Chul Lee, Kyung Koo Kang, Sang Eun Kim,